Common use of No Price Stabilization or Manipulation; Compliance with Regulation M Clause in Contracts

No Price Stabilization or Manipulation; Compliance with Regulation M. The Company has not taken, directly or indirectly, any action designed to or that might be reasonably expected to cause or result in stabilization or manipulation of the price of the Offered ADSs or Ordinary Shares or any other “reference security” (as defined in Rule 100 of Regulation M under the Exchange Act (“Regulation M”)) whether to facilitate the sale or resale of the Offered ADSs, the Ordinary Shares or otherwise, and has taken no action which would directly or indirectly violate Regulation M.

Appears in 3 contracts

Samples: Underwriting Agreement (Luxfer Holdings PLC), Underwriting Agreement (Celsus Therapeutics Plc.), Underwriting Agreement (Luxfer Holdings PLC)

AutoNDA by SimpleDocs

No Price Stabilization or Manipulation; Compliance with Regulation M. The Neither the Company nor any of its subsidiaries has not taken, directly or indirectly, any action designed to or that might be reasonably expected to cause or result in stabilization or manipulation of the price of the Offered ADSs or Ordinary Shares or of any other “reference security” (as defined in Rule 100 of Regulation M under the Exchange Act (“Regulation M”)) with respect to the Offered ADSs, whether to facilitate the sale or resale of the Offered ADSs, the Ordinary Shares ADSs or otherwise, and has taken no action which would directly or indirectly violate Regulation M.

Appears in 3 contracts

Samples: Underwriting Agreement (I-Mab), Underwriting Agreement (Avadel Pharmaceuticals PLC), Underwriting Agreement (I-Mab)

No Price Stabilization or Manipulation; Compliance with Regulation M. The Neither the Company nor any of its subsidiaries has not taken, directly or indirectly, any action designed to or that might would reasonably be reasonably expected to cause or result in stabilization or manipulation of the price of the Offered ADSs or Ordinary Shares or of any other “reference security” (as defined in Rule 100 of Regulation M under the Exchange Act (“Regulation M”)) with respect to the Offered ADSs, whether to facilitate the sale or resale of the Offered ADSs, the Ordinary Shares ADSs or otherwise, and has taken no action which would directly or indirectly violate Regulation M.

Appears in 2 contracts

Samples: Underwriting Agreement (Connect Biopharma Holdings LTD), Underwriting Agreement (Nightstar Therapeutics LTD)

No Price Stabilization or Manipulation; Compliance with Regulation M. The Neither the Company nor any of its subsidiaries has not taken, directly or indirectly, without giving effect to any activities by the Underwriters, any action designed to or that might reasonably be reasonably expected to cause or result in stabilization or manipulation of the price of the Offered ADSs or Ordinary Shares or of any other “reference security” (as defined in Rule 100 of Regulation M under the Exchange Act (“Regulation M”)) with respect to the Offered ADSs, whether to facilitate the sale or resale of the Offered ADSs, the Ordinary Shares ADSs or otherwise, and has taken no action which would directly or indirectly violate Regulation M.

Appears in 2 contracts

Samples: Argo Blockchain PLC, Argo Blockchain PLC

No Price Stabilization or Manipulation; Compliance with Regulation M. The Neither the Company nor any of its subsidiaries has not taken, directly or indirectly, any action designed to or that might be reasonably expected to cause or result in stabilization or manipulation of the price of the Offered ADSs or Ordinary Common Shares or of any other “reference security” (as defined in Rule 100 of Regulation M under the Exchange Act (“Regulation M”)) with respect to the ADSs or Common Shares, whether to facilitate the sale or resale of the Offered ADSs, the Ordinary Shares ADSs or otherwise, and has taken no action which would directly or indirectly violate Regulation M.

Appears in 1 contract

Samples: Open Market Sale (Purple Biotech Ltd.)

No Price Stabilization or Manipulation; Compliance with Regulation M. The Neither the Company nor any of its subsidiaries and consolidated affiliated entities or any of their respective directors, officers or affiliates has not taken, directly or indirectly, any action designed to or that might be reasonably expected to cause or result in stabilization or manipulation of the price of the Offered ADSs or Ordinary Shares or of any other “reference security” (as defined in Rule 100 of Regulation M under the Exchange Act (“Regulation M”)) with respect to the Offered ADSs, whether to facilitate the sale or resale of the Offered ADSs, the Ordinary Shares ADSs or otherwise, and has taken no action which would directly or indirectly violate Regulation M.

Appears in 1 contract

Samples: Secoo Holding LTD

No Price Stabilization or Manipulation; Compliance with Regulation M. The Company has not taken, directly or indirectly, any action designed to or that might be reasonably expected to cause or result in stabilization or manipulation of the price of the Offered ADSs or Ordinary Shares or any other “reference security” (as defined in Rule 100 of Regulation M under the Exchange 1934 Act (“Regulation M”)) whether to facilitate the sale or resale of the Offered ADSs, the Ordinary Shares ADSs or otherwise, and has taken no action which would directly or indirectly violate Regulation M. The Company acknowledges that the Underwriters may engage in passive market making transactions in the Offered ADSs on the New York Stock Exchange in accordance with Regulation M.

Appears in 1 contract

Samples: Underwriting Agreement (Lentuo International Inc.)

AutoNDA by SimpleDocs

No Price Stabilization or Manipulation; Compliance with Regulation M. The Company has not taken, directly or indirectly, any action designed to or that might be reasonably expected to cause or result in stabilization or manipulation of the price of the Offered ADSs or ADSs, the Ordinary Shares or any other “reference security” (as defined in Rule 100 of Regulation M under the Exchange 1934 Act (“Regulation M”)) whether to facilitate the sale or resale of the Offered ADSs, Shares or the Ordinary Shares Offered ADSs or otherwise, and has taken no action which would directly or indirectly violate Regulation M.

Appears in 1 contract

Samples: Underwriting Agreement (Mindray Medical International LTD)

No Price Stabilization or Manipulation; Compliance with Regulation M. The Company None of the Selling Shareholders has not taken, directly or indirectly, any action designed to or that might be reasonably expected to cause or result in stabilization or manipulation of the price of the Offered ADSs or Ordinary Shares or of any other “reference security” (as defined in Rule 100 of Regulation M under the Exchange Act (“Regulation M”)) with respect to the Offered ADSs, whether to facilitate the sale or resale of the Offered ADSs, the Ordinary Shares ADSs or otherwise, and has taken no action which would directly or indirectly violate Regulation M.

Appears in 1 contract

Samples: Underwriting Agreement (I-Mab)

No Price Stabilization or Manipulation; Compliance with Regulation M. The Neither the Company nor any of its subsidiaries has not taken, directly or indirectly, without giving effect to activities by the Underwriters, any action designed to or that might would reasonably be reasonably expected to cause or result in stabilization or manipulation of the price of the Offered ADSs or Ordinary Shares or of any other “reference security” (as defined in Rule 100 of Regulation M under the Exchange Act (“Regulation M”)) with respect to the Offered ADSs, whether to facilitate the sale or resale of the Offered ADSs, the Ordinary Shares ADSs or otherwise, and has taken no action which would directly or indirectly violate Regulation M.

Appears in 1 contract

Samples: Underwriting Agreement (Stealth BioTherapeutics Corp)

No Price Stabilization or Manipulation; Compliance with Regulation M. The Neither the Company nor any of its subsidiaries or any of their respective directors, officers or affiliates has not taken, directly or indirectly, any action designed to or that might be reasonably expected to cause or result in stabilization or manipulation of the price of the Offered ADSs or Ordinary Shares or of any other “reference security” (as defined in Rule 100 of Regulation M under the Exchange Act (“Regulation M”)) with respect to the Offered ADSs, whether to facilitate the sale or resale of the Offered ADSs, the Ordinary Shares ADSs or otherwise, and has taken no action which would directly or indirectly violate Regulation M.

Appears in 1 contract

Samples: Underwriting Agreement (Yintech Investment Holdings LTD)

Time is Money Join Law Insider Premium to draft better contracts faster.